Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Interest Expenses (2020 - 2021)

Foghorn Therapeutics (FHTX) has 2 years of Interest Expenses data on record, last reported at $426000.0 in Q4 2021.

  • For Q4 2021, Interest Expenses rose 32.71% year-over-year to $426000.0; the TTM value through Sep 2022 reached $426000.0, down 76.35%, while the annual FY2021 figure was $1.9 million, 94.69% up from the prior year.
  • Interest Expenses reached $426000.0 in Q4 2021 per FHTX's latest filing, down from $499000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $499000.0 in Q3 2021 and bottomed at $198000.0 in Q2 2020.